Cogent Biosciences, Inc. Liquidation Value
COGT
Other
Cash & Equivalents
$312.01M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $312.01M
Total Obligations: -$302.75M
$9.26M
Per share: $0.06
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $312.01M
AR: $0
Total Obligations: -$302.75M
$9.26M
Per share: $0.06
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $312.01M
AR: $0
Inventory: $0
Total Obligations: -$302.75M
$9.26M
Per share: $0.06
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $9.26M | $0.06 |
| Liquid Liquidation Value | $9.26M | $0.06 |
| Operating Liquidation Value | $9.26M | $0.06 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $312.01M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $63.95M |
| Long-term Debt | $222.90M |
| Op. Lease Liability | $15.90M |
| Finance Lease | N/A |
| Shares Outstanding | 161.0M |
Explore all 151 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $312.01M | N/A | N/A | $9.50M | $63.95M | $222.90M | $15.90M | N/A |
| 2025-09-30 | $125.30M | N/A | N/A | $16.03M | $62.25M | $44.25M | $16.31M | N/A |
| 2025-06-30 | $127.60M | N/A | N/A | $16.62M | $58.42M | $43.95M | $16.71M | N/A |
| 2025-03-31 | $126.00M | N/A | N/A | $14.15M | $49.32M | N/A | $17.09M | N/A |
| 2024-12-31 | $98.17M | N/A | N/A | $12.01M | $55.71M | $0 | $17.47M | N/A |
| 2024-09-30 | $97.05M | N/A | N/A | $15.06M | $53.05M | N/A | $17.83M | N/A |
| 2024-06-30 | $88.22M | N/A | N/A | $8.97M | $40.00M | N/A | $18.18M | N/A |
| 2024-03-31 | $215.80M | N/A | N/A | $15.56M | $36.69M | N/A | $18.52M | N/A |
▼ Community Notes